{
    "title": "BioNTech reduces drug development spend as COVID vaccine sales plunge",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12380579/BioNTech-reduces-drug-development-spend-COVID-vaccine-sales-plunge.html",
    "date": "2023-08-07",
    "keywords": [
        "year",
        "partner",
        "company",
        "burger",
        "development",
        "budget",
        "revenue",
        "profit",
        "patricia",
        "frankfurt",
        "covid19",
        "drug",
        "plunge",
        "demand",
        "secondquarter",
        "share",
        "biontech",
        "loss",
        "uncertainty",
        "line",
        "spending",
        "cost",
        "base",
        "finance",
        "chief",
        "ambition",
        "multiproduct",
        "oncology",
        "disease",
        "research",
        "rampd",
        "bid",
        "work",
        "cancer",
        "tuberculosis",
        "latestage",
        "string",
        "alliance",
        "outlook",
        "vaccine",
        "boost",
        "inoculation",
        "campaign",
        "fall",
        "xbb15",
        "omicron",
        "subvariant",
        "pfizer",
        "september",
        "approval",
        "miranda",
        "murray",
        "heine",
        "louise"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}